Israel to present COVID booster-shot data to FDA

pharmafile | September 6, 2021 | News story | Sales and Marketing  

This month Israel will present COVID booster-shot data to the FDA, which is weighing White House plans to begin a booster drive in the United States.

Sharon Alroy-Preis, Head of Public Health at Israel’s Health Ministry, said the ministry had been asked by the FDA to brief its advisors.

A third booster shot of the Pfizer vaccine will be discussed, and potentially others.

Alroy-Preis told Israeli Channel 12 TV news: “We have been asked to come and present Israel’s experience and our data so that we can truly help the whole world to learn.”

A week ago the country began offering a Pfizer COVID-19 booster to people as young as 12.

Israeli health officials said the drive has slowed a rise in severe illness caused by the now-dominant Delta variant.

Officials say this is due to effectiveness waning of the Pfizer vaccine after five to six months. It is said that a third shot restores the protection of the second shot.

In Israel, 2.6 million people out of a population of 9.3 million have received three doses of the Pfizer vaccine.

Lilly Subbotin

Related Content

No items found

Latest content